Cited 0 time in
Disorganization of Retinal Inner Layers in Diabetic Macular Edema Treated with a Dexamethasone Implant
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Byoung Seon | - |
| dc.contributor.author | Lee, Dong Woo | - |
| dc.contributor.author | Cho, Yong Wun | - |
| dc.contributor.author | Yoo, Woong-Sun | - |
| dc.contributor.author | Seo, Seong-Wook | - |
| dc.contributor.author | Chung, Young | - |
| dc.date.accessioned | 2022-12-26T12:17:59Z | - |
| dc.date.available | 2022-12-26T12:17:59Z | - |
| dc.date.issued | 2020-10 | - |
| dc.identifier.issn | 0378-6471 | - |
| dc.identifier.issn | 2092-9374 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/6113 | - |
| dc.description.abstract | Purpose: To evaluate the correlation between visual acuity (VA) and the disorganization of retinal inner layers (DRIL) after use of an intravitreal dexamethasone implant to treat diabetic macular edema (DME). Methods: The clinical records of 25 patients with DME treated with an intravitreal dexamethasone implant were reviewed. Best corrected visual acuity (BCVA) and spectral domain optical coherence tomography data were analyzed from each visit. Results: The BCVAs at 1 month and 3 months after treatment were statistically significant with respect to the baseline BCVA of DME patients (p = 0.021, p < 0.001, respectively); however no statistically significant change was evident at the 6 months follow-up (p = 0.062). Also, the DRIL degree at 1 month and 3 months after treatment was statistically significant with respect to baseline DRIL ( p = 0.034, p < 0.001); however, there was no statistically significant change at 6 months after treatment (p = 0.052). The BCVA at 6 months after treatment was positively and significantly correlated with the baseline BCVA (p < 0.001, R-2 = 0.705), CRT (p = 0.032, R-2 = 0.308), and DRIL extent (p = 0.024, R-2 = 0.201). Conclusions: The BCVA in patients after treatment with an intravitreal dexamethasone implant for DME was related to the change in the CRT after treatment. The baseline BCVA and change in the DRIL may be important indicators for predicting VA improvement in DME. | - |
| dc.format.extent | 8 | - |
| dc.language | 한국어 | - |
| dc.language.iso | KOR | - |
| dc.publisher | 대한안과학회 | - |
| dc.title | Disorganization of Retinal Inner Layers in Diabetic Macular Edema Treated with a Dexamethasone Implant | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.3341/jkos.2020.61.10.1169 | - |
| dc.identifier.scopusid | 2-s2.0-85095413437 | - |
| dc.identifier.wosid | 000582463200008 | - |
| dc.identifier.bibliographicCitation | 대한안과학회지, v.61, no.10, pp 1169 - 1176 | - |
| dc.citation.title | 대한안과학회지 | - |
| dc.citation.volume | 61 | - |
| dc.citation.number | 10 | - |
| dc.citation.startPage | 1169 | - |
| dc.citation.endPage | 1176 | - |
| dc.type.docType | Article | - |
| dc.identifier.kciid | ART002636437 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | esci | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Ophthalmology | - |
| dc.relation.journalWebOfScienceCategory | Ophthalmology | - |
| dc.subject.keywordPlus | CONTROLLED-TRIAL | - |
| dc.subject.keywordPlus | VISUAL-ACUITY | - |
| dc.subject.keywordAuthor | Dexamethasone | - |
| dc.subject.keywordAuthor | Diabetic macular edema | - |
| dc.subject.keywordAuthor | Disorganization of retinal inner layer | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
